US proposes new restrictions on investment in sensitive technologies in China

The U.S. government has proposed new restrictions on American investments in sensitive technology sectors in China, including AI and biotechnology. These regulations aim to enhance national security by controlling investments in advanced semiconductors and military-related technologies. The proposals will undergo public consultation before final approval and are part of efforts to limit China's access to critical technologies. Concerns have been raised about the implications for the biotech industry, which relies on Chinese partnerships for drug development. Major pharmaceutical companies may be exempt from some restrictions if payments are made in cash without equity stakes.